secwatch / observer
8-K filed February 1, 2024, 6:59 PM ET ticker DGX CIK 0001022079
earnings confidence high sentiment positive materiality 0.80

Quest Diagnostics Q4 2023 adjusted EPS $2.15, +8.6%; base business revenue +4.7%

QUEST DIAGNOSTICS INC

2023-FY EPS reported $7.49 revenue$9,252,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

QUEST DIAGNOSTICS INC reported quarter and full year ended December 31, 2023 results: revenue Fourth quarter revenues of $2.29 billion, EPS Fourth quarter reported diluted earnings per share ("EPS") of $1.70. Guidance initiated.

Period
quarter and full year ended December 31, 2023
Revenue
Fourth quarter revenues of $2.29 billion
EPS
Fourth quarter reported diluted earnings per share ("EPS") of $1.70
Guidance
initiated
Result
reported results
Exact text from the filing
Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share • Fourth quarter revenues of $2.29 billion, down 1.9% from 2022 • Fourth quarter reported diluted earnings per share ("EPS") of $1.70, up 95.4% from 2022; and adjusted diluted EPS of $2.15, up 8.6% from 2022 • Fourth
View on SEC.gov

Browse all earnings releases →

QUEST DIAGNOSTICS INC filing history →

Source: SEC EDGAR
accession 0001022079-24-000009
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.